Myopia Management: What Is It and Does My Child Need It?
What is myopia management?
Myopia management refers to strategies that aim to slow myopia progression (slowing how quickly a child becomes more nearsighted and how quickly the eye elongates).
Regular glasses can correct blur — but they don’t necessarily slow eye growth.
That matters because higher myopia is associated with increased lifetime risk of sight-threatening conditions such as retinal detachment, glaucoma, and myopic macular changes (risk increases with higher levels of myopia). (General principle; not tied to one single study.)
Who tends to benefit most?
Children who:
Develop myopia at a younger age
Progress quickly year to year
Have one or two myopic parents
Have high near-work demands and limited outdoor time
Evidence-based options
1) Low-dose atropine eye drops
A major randomized, placebo-controlled trial (LAMP) found that low-concentration atropine slowed myopia progression in a dose-dependent manner over 1 year, with 0.05% performing best among the studied concentrations.
Nuance matters here:
A large U.S.-based randomized clinical trial reported 0.01% atropine did not significantly slow progression versus placebo in that study population.
What this means: concentration, patient selection, and protocol matter; “low-dose atropine” is not one-size-fits-all.
2) Myopia-control soft contact lenses (daily disposables)
A 3-year randomized, double-masked clinical trial showed that a myopia-control soft lens design (MiSight) slowed myopia progression over multiple years compared with a single-vision control lens.
3) Myopia-control spectacle lenses (e.g., DIMS designs)
Randomized trial evidence supports that DIMS-style spectacle lenses can slow myopia progression and axial elongation in children compared with standard single-vision lenses.
4) Orthokeratology (Ortho-K)
Ortho-K has a substantial evidence base for reducing axial elongation compared with single-vision correction, though outcomes can vary by patient factors and lens fit; it also requires strong hygiene and follow-up adherence. (If you want, I can pull and cite a specific high-quality meta-analysis from before 2025 to anchor this section.)
Do all children with myopia “need” management?
Not always.
A child may be best served by:
Monitoring + lifestyle changes (especially early or borderline “premyopia”)
Or active myopia management if progression risk is higher
A practical decision framework uses:
Age of onset
Rate of change over time
Current prescription/axial length (if measured)
Family history
Visual lifestyle and feasibility of treatment
The goal
The goal is not “no glasses.”
It’s slowing progression to reduce the chance of reaching higher myopia levels — and supporting healthier eyes long-term.
